Investors in AGL have chance to take the lead in agilon health securities fraud lawsuit

Investors who have bought agilon health, inc. (“Agilon” or “the Company”) shares during the period from February 26, 2025, to August 4, 2025, should be aware of the class action lawsuit filed by The Schall Law Firm. The lawsuit alleges violations of federal securities laws and the Securities Exchange Act of 1934 due to false and misleading statements made by the Company to the market during the Class Period.

According to the complaint, Agilon provided guidance for the year 2026 that was unrealistic and overstated the impact of its risk reduction efforts. This led to the dissemination of false and materially misleading information during the entire Class Period. When the market discovered the truth about Agilon, investors suffered financial losses.

It is essential for affected shareholders to reach out to The Schall Law Firm before March 2, 2026, to ensure their rights are protected. Failure to take action could result in being excluded from the class. To discuss your options, contact Brian Schall of The Schall Law Firm in Los Angeles.

The Class has not been certified yet, and until it is, investors are not officially represented by an attorney. Investors who choose not to participate actively will still be considered absent class members. It is crucial for investors to join the case to seek recovery for their losses.

The Schall Law Firm is experienced in handling securities class action lawsuits and shareholder rights litigation worldwide. Their expertise in representing investors in legal matters related to securities fraud is well-recognized.

For more information or to contact The Schall Law Firm, visit their website or call their office directly. It is important to act promptly to protect your rights and interests as an investor. Remember that this press release may be considered Attorney Advertising in certain jurisdictions, based on local laws and rules of ethics.